Beyond Biotech podcast 29: Janssen, Knowledge Gate
This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince,…
January 12, 2023 - 2 minutes
Janssen
Janssen looks for talquetamab marketing approval
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA)…
January 3, 2023 - 2 minutes
ASPIRE set up to collaborate on amyloidosis
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research…
October 4, 2022 - 3 minutes
Synairgen to collaborate on study of patients hospitalized due to respiratory viruses
Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral…
September 5, 2022 - 3 minutes
Hope for children with chronic graft versus host disease as Johnson & Johnson drug approved
A treatment for chronic graft versus host disease in children aged one year and older…
August 25, 2022 - 3 minutes
Collaboration to advance investigational tuberculosis drug treatments
A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday…
August 18, 2022 - 5 minutes
Yumanity selling neurology assets and merging with Kineta
U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate…
June 7, 2022 - 3 minutes
Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
February 15, 2022 - 7 minutes
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
December 20, 2019 - 2 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
October 31, 2019 - 2 minutes
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
August 22, 2019 - 2 minutes
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could…
June 11, 2019 - 2 minutes
